2012 Fiscal Year Final Research Report
Identification of therapeutic targets for ALS by screening for TDP-43 and FUS associated molecules
Project/Area Number |
23659452
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Neurology
|
Research Institution | Nagoya University |
Principal Investigator |
SOBUE Gen 名古屋大学, 医学系研究科, 教授 (20148315)
|
Project Period (FY) |
2011 – 2012
|
Keywords | 筋萎縮性側索硬化症 |
Research Abstract |
Mouse primary cortical neurons were silenced with FUS by introducing lentivirus encoding shRNA against FUS gene. We next established the FUS-regulated transcriptome profiles of primary neurons using exon-sensitive microarrays and identified that FUS regulated the alternative splicing of Mapt exon10. This alternative splicing event results in three-repeats (RD3) and four-repeats (RD4) Tau isoform production and the ratio of RD4/RD3 was increased when FUS was silenced in neurons. Morphological abnormality of neurite was observed in FUS-silenced primary neurons and it was rescued bysilencing of RD4. These findings suggest that RD4 could be a therapeutic target for ALS treatment.
|
-
[Journal Article] Loss of TDP-43 causes age-dependent progressive motor neuron degeneration2013
Author(s)
Iguchi Y, Katsuno M, Niwa JI, Takagi S, Ishigaki S, Ikenaka K, Kawai K, Watanabe H, Yamanaka K, Takahashi R, Misawa H, Sasaki S, Tanaka F, Sobue G
Volume
136(Pt5)
Pages
1371-82
DOI
Peer Reviewed
-
-
-
-
-
-
-
-